Anavex Life Sciences Corp (AVXL)

[MayoMobile]

Our January 2023 roundup is upon us! We believe most viewers will get good value out of the first ~17:40 minutes of this video which includes an overview of Cassava Science's ($SAVA) Phase 2 Alzheimer's Top-Line Data (cognition only) and elucidation of Blarcamesine's restorative neurogenesis abilities - partially by harnessing the power of the CDK5 gene. Beyond 17 minutes, viewers can get a more in-depth look at serotonin, as well as S1R enhancement in diabetes-induced dementia. My next video will likely be in mid-to-late February after an in-person interview with Dr. Timo Grimmer in Munich, Germany.

P.S. It's hard saying Simufilam correctly!